Monday, April 13, 2015

Methodology: descriptive study, retrospective case presentations. The study is taking place at the

There is a theoretical relationship between wd40 the occurrence of lactic acidosis wd40 and the use of drugs containing propylene glycol at high doses for prolonged periods. We conducted a retrospective study from a series of six pediatric patients who received pentobarbital, phenytoin wd40 or phenobarbital for at least 12 hours. No cases of lactic wd40 acidosis have been reported in six patients.
Objectives: To evaluate the presence of lactic wd40 acidosis in patients treated with phenytoin (8.29 mg / mL PG), pentobarbital (8.31 mg / ml PG) and phenobarbital (6.56 mg / mL PG) to pediatric intensive care.
Methodology: descriptive study, retrospective case presentations. The study is taking place at the CHU Sainte-Justine, a mother-child facility with 500 beds. From the pharmacological computerized record, we identified patients receiving phenytoin, phenobarbital and pentobarbital for a period of at least 12 hours. Were included all patients from January 1 to December 31, 2011. For each patient, we calculated the dose in mg / kg / day received PG calculated osmolar gap and documented blood pH.
Results: Six patients received combinations of these three medications for episodes 4-15 days of treatment for a total cumulative dose of PG 964-3184 mg / kg. All patients received pentobarbital and phenytoin; two patients received phenobarbital. Patients received No patient had lactic acidosis with minimum and maximum wd40 values of pH [7.37-7.44] and average values of osmolar gap of 7.4, respectively; wd40 9.1; 11.3; 12.1; 18.3 and 18.4.
Conclusion: The use of drugs with PG includes theoretical risk of lactic wd40 acidosis. No cases were reported in six patients treated with three drugs containing PG. It does not appear useful to monitoring the serum PG. However, a study in a larger number of higher cumulative doses to patients could be considered.
On the same theme This entry was posted in Good use of drugs, Case, side effects, morbidity, Pharmaceutical Care, RUPP and marked with lactic acidosis, pentobarbital, phenobarbital, phenytoin, propylene glycol, December 11, 2014 by Cynthia Tanguay. Navigation How to define an Author? Management of rare inherited metabolic disorders at the CHU Sainte-Justine
Pages About Annals of RUPP Team Links Recipes Stages Themes, quotes and RUPP markers on the Web Blog History of Pharmacy in Quebec Pharmacy Blog Blog Impact Legislation and care systems - Pharmacy CHUSJ RUPP RUPP on Facebook RUPP RUPP on LinkedIn RUPP on Twitter Zotero Archives April 2015 March 2015 February 2015 January 2015 December 2014 November 2014 October 2014 September 2014 August 2014 July 2014 June 2014 May 2014 April 2014 March 2014 February 2014 January 2014 December 2013 November 2013 October wd40 2013 September 2013 August 2013 July 2013 June 2013 May 2013 April 2013 March 2013 February 2013 January 2013 December 2012 November 2012 October 2012 September 2012 August 2012 July 2012 June 2012 May 2012 April 2012 March 2012 February 2012 January 2012 December 2011 November 2011 October 2011 September 2011 July 2011 June 2011 May 2011 April 2011 March 2011 RUPP's News in RSS format RSS - Articles Our categories Annals of Pharmacy Practice Research Unit (22) Original article (3) Other notes (24) Work (128) Before / after (11) Case (5) Case-control (2) Cohort (15) Review article (6) Descriptive (70) Discussion Group (4) Guideline (1) Comments (7) Expert Opinion (13) Quasi-randomized ( 1) Literature Review (39) Systematic review (1) Poll (8) Transversal (5) Congratulations and references (46) Markers results (87) Other markers (31) Costs (20) side effects (23) Errors (27 ) Morbidity (15) mortality (2) Observance (10) Satisfaction (3) Revenue of pharmacy practice research unit (2) Occupational safety and health (1) Pharmaceutical Care (2) Research interests (199) Good drug use (56) Medication Management (85) History of pharmacy (7) Pharmaceutical legislation (14) Health Education (29) Pharmacoeconomics (6) Clinical Research (7) Occupational safety and health (29) Pharmaceutical Care ( 42) Technology (29) RUPP (236) Tweet pharmaceutical practice Haiti - 3rd humanitarian mission 4 days ago What are the effects of the involvement of pharmacists in direct patient care? 5 days ago 2 months before the Symposium RUPP / Paris Descartes 1 week ago What impact does the pharmacist in the management of warfarin therapy?

No comments:

Post a Comment